Barclays PLC Axogen, Inc. Transaction History

Barclays PLC

$377 Billion
Q3 2024

A detailed history of Barclays PLC transactions in Axogen, Inc. stock. As of the latest transaction made, Barclays PLC holds 72,036 shares of AXGN stock, worth $1.17 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

72,036

Previous 72,036 -0.0%

Holding current value

$1.17 Million

Previous $1.01 Million -0.0%

% of portfolio

0.0%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	BUY	$7.52 - $14.69 $294,648 - $575,583	39,182 Added 119.26%	72,036 $1.01 Million
Q2 2024 Aug 14, 2024	SELL	$5.67 - $8.06 $51,999 - $73,918	-9,171 Reduced 21.82%	32,854 $239,000
Q1 2024 May 15, 2024	SELL	$6.63 - $10.69 $184,658 - $297,737	-27,852 Reduced 39.86%	42,025 $339,000
Q4 2023 Feb 15, 2024	BUY	$3.61 - $7.76 $148,811 - $319,882	41,222 Added 143.86%	69,877 $477,000
Q3 2023 Nov 07, 2023	BUY	$4.68 - $9.26 $20,531 - $40,623	4,387 Added 18.08%	28,655 $142,000
Q2 2023 Aug 03, 2023	SELL	$8.5 - $10.38 $43,715 - $53,384	-5,143 Reduced 17.49%	24,268 $222,000
Q1 2023 May 04, 2023	BUY	$7.53 - $10.95 $72,626 - $105,612	9,645 Added 48.8%	29,411 $278,000
Q4 2022 Feb 13, 2023	BUY	$9.44 - $13.09 $86,536 - $119,996	9,167 Added 86.49%	19,766 $197,000
Q3 2022 Nov 03, 2022	SELL	$8.14 - $12.25 $2,572 - $3,871	-316 Reduced 2.9%	10,599 $126,000
Q2 2022 Aug 12, 2022	SELL	$6.99 - $10.0 $30,930 - $44,250	-4,425 Reduced 28.85%	10,915 $90,000
Q1 2022 May 16, 2022	SELL	$7.26 - $10.7 $290,821 - $428,620	-40,058 Reduced 72.31%	15,340 $122,000
Q4 2021 Feb 14, 2022	BUY	$8.8 - $16.0 $249,128 - $452,960	28,310 Added 104.51%	55,398 $519,000
Q3 2021 Nov 09, 2021	BUY	$15.23 - $21.72 $165,108 - $235,466	10,841 Added 66.73%	27,088 $429,000
Q2 2021 Aug 13, 2021	SELL	$17.8 - $23.5 $501,212 - $661,713	-28,158 Reduced 63.41%	16,247 $352,000
Q1 2021 May 13, 2021	BUY	$17.18 - $22.6 $182,296 - $239,808	10,611 Added 31.4%	44,405 $900,000
Q4 2020 Feb 11, 2021	SELL	$11.5 - $17.96 $56,821 - $88,740	-4,941 Reduced 12.76%	33,794 $605,000
Q3 2020 Nov 12, 2020	SELL	$10.62 - $13.12 $90,567 - $111,887	-8,528 Reduced 18.04%	38,735 $450,000
Q2 2020 Aug 12, 2020	BUY	$7.35 - $10.81 $184,301 - $271,060	25,075 Added 113.01%	47,263 $437,000
Q1 2020 May 13, 2020	SELL	$8.38 - $17.34 $172,292 - $356,510	-20,560 Reduced 48.1%	22,188 $230,000
Q4 2019 Feb 10, 2020	BUY	$11.18 - $18.6 $172,731 - $287,370	15,450 Added 56.6%	42,748 $766,000
Q3 2019 Nov 14, 2019	SELL	$12.09 - $20.46 $193,210 - $326,971	-15,981 Reduced 36.93%	27,298 $341,000
Q2 2019 Aug 14, 2019	SELL	$18.5 - $25.47 $3.19 Million - $4.4 Million	-172,624 Reduced 79.95%	43,279 $857,000
Q1 2019 May 15, 2019	BUY	$14.62 - $22.13 $3.02 Million - $4.58 Million	206,737 Added 2255.48%	215,903 $4.55 Million
Q4 2018 Feb 14, 2019	SELL	$17.09 - $38.25 $274,704 - $614,830	-16,074 Reduced 63.68%	9,166 $187,000
Q3 2018 Nov 14, 2018	BUY	$34.05 - $55.9 $705,890 - $1.16 Million	20,731 Added 459.77%	25,240 $930,000
Q2 2018 Aug 14, 2018	SELL	$36.15 - $52.5 $113,908 - $165,427	-3,151 Reduced 41.14%	4,509 $227,000
Q1 2018 May 15, 2018	BUY	$24.4 - $40.25 $79,763 - $131,577	3,269 Added 74.45%	7,660 $280,000
Q4 2017 Feb 14, 2018	BUY	$18.5 - $28.6 $69,541 - $107,507	3,759 Added 594.78%	4,391 $125,000
Q3 2017 Nov 14, 2017	BUY	$14.65 - $19.35 $9,258 - $12,229	632	632 $12,000

Others Institutions Holding AXGN

# of Institutions

162

Shares Held

36.6M

Call Options Held

230K

Put Options Held

400

View Full List

About Axogen, Inc.

Ticker AXGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 42,283,700
Market Cap $688M
Description
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...

More about AXGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account